These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22248636)

  • 1. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor.
    Ruzza C; Pulga A; Rizzi A; Marzola G; Guerrini R; Calo' G
    Neuropharmacology; 2012 Apr; 62(5-6):1999-2009. PubMed ID: 22248636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
    Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
    Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze.
    Pulga A; Ruzza C; Rizzi A; Guerrini R; Calo G
    Eur J Neurosci; 2012 Dec; 36(11):3531-7. PubMed ID: 22928868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
    Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
    Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of central neuropeptide S in the mouse formalin test.
    Peng YL; Zhang JN; Chang M; Li W; Han RW; Wang R
    Peptides; 2010 Oct; 31(10):1878-83. PubMed ID: 20603169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
    Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
    Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
    Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
    Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response.
    Fendt M; Buchi M; Bürki H; Imobersteg S; Ricoux B; Suply T; Sailer AW
    Behav Brain Res; 2011 Feb; 217(1):1-9. PubMed ID: 20888368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor.
    Peng YL; Han RW; Chang M; Zhang L; Zhang RS; Li W; Han YF; Wang R
    Peptides; 2010 Dec; 31(12):2259-63. PubMed ID: 20800637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
    Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
    Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
    Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
    Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1).
    Tordera RM; Totterdell S; Wojcik SM; Brose N; Elizalde N; Lasheras B; Del Rio J
    Eur J Neurosci; 2007 Jan; 25(1):281-90. PubMed ID: 17241289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.
    Clark SD; Duangdao DM; Schulz S; Zhang L; Liu X; Xu YL; Reinscheid RK
    J Comp Neurol; 2011 Jul; 519(10):1867-93. PubMed ID: 21452235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
    Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
    Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
    Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
    Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical response to the sedative effects of diazepam and alcohol in C57BL/6J mice lacking the neuropeptide S receptor.
    Ghazal P; Corsi M; Roth A; Faggioni F; Corti C; Merlo Pick E; Pucciarelli S; Ciccocioppo R; Ubaldi M
    Peptides; 2014 Nov; 61():107-13. PubMed ID: 25240770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
    Xu YL; Reinscheid RK; Huitron-Resendiz S; Clark SD; Wang Z; Lin SH; Brucher FA; Zeng J; Ly NK; Henriksen SJ; de Lecea L; Civelli O
    Neuron; 2004 Aug; 43(4):487-97. PubMed ID: 15312648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral phenotyping of neuropeptide S receptor knockout mice.
    Duangdao DM; Clark SD; Okamura N; Reinscheid RK
    Behav Brain Res; 2009 Dec; 205(1):1-9. PubMed ID: 19646487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR26-deficient mice display increased anxiety- and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala.
    Zhang LL; Wang JJ; Liu Y; Lu XB; Kuang Y; Wan YH; Chen Y; Yan HM; Fei J; Wang ZG
    Neuroscience; 2011 Nov; 196():203-14. PubMed ID: 21924326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
    Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
    J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.